Schedule 13D ownership disclosure
QUOIN PHARMACEUTICALS LTD
Ordinary Shares, no par value per share (represented by American Depositary Shares) · CUSIP: 74907L300
Event date: 2025-01-27
- Filing-level shares
- 939,238.00
- Percent of class
- 4.9%
- Denise CarterReported CIK 0001958621
Shares: 939,238.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-006733
- Form type
- SCHEDULE 13D/A
- Filer
- Carter Denise P.
- CIK
- CIK 1958621
- Filed
- Jan 28, 2025
- Reporting period
- Jan 27, 2025
- Description
- Schedule 13D beneficial ownership